Construction of model for multidimensional evaluation of value and risk of Chinese patent medicine.
10.19540/j.cnki.cjcmm.20201214.601
- Author:
Geng LI
1
;
Zhen-Kun LI
2
;
Hong-Jun YANG
3
;
Zhi-Lai ZHAN
4
;
Hong-Mei LI
3
;
Shi-Huan TANG
3
Author Information
1. China-Japan Friendship Hospital Beijing 100029,China.
2. Beijing Big Brand League Technology Consulting Co.,Ltd. Beijing 100070,China.
3. Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences Beijing 100070,China.
4. Chinese Medicine Resource Center,China Academy of Chinese Medical Sciences Beijing 100070,China.
- Publication Type:Journal Article
- Keywords:
Chinese patent medicine;
large variety of traditional Chinese medicine;
model;
multidimensional evaluation;
risk control
- MeSH:
China;
Drugs, Chinese Herbal/adverse effects*;
Medicine, Chinese Traditional;
Nonprescription Drugs/adverse effects*;
Quality Control
- From:
China Journal of Chinese Materia Medica
2021;46(5):1284-1292
- CountryChina
- Language:Chinese
-
Abstract:
It is the core of the development for Chinese patent medicine enterprises to cultivate large varieties of Chinese patent medicine, and the selection of potential "seed" products is the prerequisite for the cultivation strategy. By constructing the evaluation model from multiple dimensions of value and risk, we can conduct specialized evaluation of Chinese patent medicines to effectively, professionally and objectively select the "seed" products with large variety cultivation potential. In this paper, the establishment of a multidimensional evaluation system would be discussed from the aspects of drug naming and prescription composition, safety risk and supply guarantee of raw materials and medicinal materials, competition situation, access to policy catalogue, scientific and technological support, clinical evidence and recognition, systematical and standardized collection of information on product instructions, quality standards, policy catalogue, scientific and technological literature, market competition and clinical application of Chinese patent medicines. Through the objective evaluation index and the range of objective index, the multi-dimensional evaluation model on values and risks of Chinese patent medicine products was discussed. Based on this model, a batch of Chinese patent medicine products can be quickly and comprehensively analyzed, and quantitative comparison can be formed among different types and fields of products. According to the evaluation results of the model and the comprehensive evaluation of experts, high-quality "seed" products can be selec-ted, laying a solid foundation for the next step of large variety cultivation. With use of this model, we can further clarify the external competitive advantages and internal priority levels of each product, and provide support for enterprises to optimize product structure and improve product strategic layout.
